MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$27,586K Refundable research incometax credits$5,491K Prepaid expenses andother current assets$3,164K Accounts receivable$873K Total current assets$37,114K Property and equipment,net$10,317K Refundable research incometax credits,...$8,759K Operating leaseright-of-use assets$2,905K Other non-currentassets$870K Total assets$59,965K Accumulated deficit-$1,658,244K Accumulated othercomprehensive loss-$2,513K Total liabilities andstockholders deficit$59,965K Total stockholdersdeficit-$18,955K Additional paid-in capital$1,637,659K Common stock$4,143K Total liabilities$78,920K Total currentliabilities$53,134K Long-term portion of leaseliabilities$19,332K Deferred revenues,non-current$5,874K Other non-currentliabilities$580K Accounts payable$19,307K Accrued compensationand employee...$18,341K Other accruedliabilities$15,084K Deferred revenues$402K
Balance Sheet

SANGAMO THERAPEUTICS, INC (SGMO)

SANGAMO THERAPEUTICS, INC (SGMO)

source: myfinsight.com